Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3364907 | 0.74 | CA1 (0.36) | CA1CA2CA12CA9EPHX1 | |
| SCHEMBL3066087 | 0.74 | CA1 (0.39) | CA1CA2CA12CA9EPHX1 | |
| SCHEMBL3086400 | 0.74 | CA1 (0.34) | CA1CA2CA12CA9EPHX1 | |
| SCHEMBL8435994 | 0.70 | — | — | |
| Biphenyl SCHEMBL11430652 | 0.69 | ALDH1A1 (0.36) | CA1CA2CA12CA9EPHX1 | |
| SCHEMBL673199 | 0.67 | CA1 (0.39) | CA1CA2CA12CA9EPHX1 | |
| SCHEMBL3066085 | 0.65 | CA1 (0.37) | CA1CA2CA12CA9EPHX1 | |
| SCHEMBL3057265 | 0.65 | CA1 (0.32) | CA1CA2CA12CA9 | |
| SCHEMBL3078082 | 0.65 | CA1 (0.36) | CA1CA2CA12CA9 | |
| SCHEMBL15941586 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190241952-A1 | TAGGED MULTI-NUCLEOTIDES USEFUL FOR NUCLEIC ACID SEQUENCING | ROCHE SEQUENCING SOLUTIONS INC (US) | 2019-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190241952-A1 | TAGGED MULTI-NUCLEOTIDES USEFUL FOR NUCLEIC ACID SEQUENCING | NT5C3B, POLN, RNGTT | CA1 4693/4885CA2 4082/4885CA12 4487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.